Combined oral contraceptive use reduces the risk of ovarian cancer by 40% and the risk of endometrial cancer by 50% compared to never users.
Use of Combined oral contraceptive lowers the risk of ovarian cancer by 40%. It also lowers the risk of endometrial cancer by 50%, compared to never users.